CRP and diabetes mellitus: In our study cohort, we observed that increased CRP levels and a high proportion of monocyte-expressing CD32 receptors were common in patients with a history of proinflammatory conditions associated with a higher risk of AHF events during the first year following their initial ACS presentation, such as lower kidney function, anemia, and diabetes.